Effect of Primary Care Education on Parents' Health-Related Perceptions and Attitudes
The Effect of Education Provided in Primary Health Care Services on Vaccine Hesitancy, Digital Vaccine Literacy, Eco-Anxiety, and Perceived Vulnerability to Diseases Among Parents of Children Aged 0-2 Years
1 other identifier
interventional
173
1 country
1
Brief Summary
This study aims to evaluate the effect of a structured education program delivered in primary health care settings on parents of children aged 0-2 years. The education focuses on childhood vaccination and related health perceptions. Parents will receive education covering childhood vaccines, vaccine hesitancy, evaluation of vaccine-related information obtained from digital sources, eco-anxiety, and perceived vulnerability to diseases. The study examines whether this education influences parents' levels of vaccine hesitancy, digital vaccine literacy, eco-anxiety, and perceived vulnerability to diseases. The findings are expected to contribute to the development of effective educational interventions in primary health care services to support informed parental decision-making regarding childhood vaccination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2026
CompletedFirst Submitted
Initial submission to the registry
January 25, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2026
CompletedApril 29, 2026
April 1, 2026
1 month
January 25, 2026
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Vaccine Hesitancy Level
Change in parents' level of vaccine hesitancy measured using the Parent Vaccine Hesitancy Scale. The scale consists of 10 items and 2 subdimensions, with items 1, 2, 3, 4, 6, and 7 reverse-coded. It includes the Lack of Confidence subdimension (items 1, 2, 3, 4, 6, 7, and 8) and the Risks subdimension (items 5, 9, and 10). The scale is rated on a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree), and the total score is calculated by summing the item scores; higher total scores indicate lower levels of vaccine hesitancy.
Baseline (pre-intervention) and 15 days after completion of the education program
Digital Vaccine Literacy Level
Change in parents' digital vaccine literacy level measured using the Digital Vaccine Literacy Scale. The scale consists of a total of 7 items and 3 subdimensions: trust in and understanding of official information (items 1-2), trust in and understanding of information on social media (items 3-4), and evaluation and application of online vaccine information (items 5-7). Each item is rated on a four-point Likert scale ranging from 1 (strongly disagree) to 4 (strongly agree). The total score ranges from 7 to 28, with higher scores indicating a higher level of digital vaccine literacy.
Baseline and 15 days after completion of the education program
Eco-Anxiety Level
Change in parents' eco-anxiety level measured using the Hogg Eco-Anxiety Scale (HEAS-13) The scale consists of 13 items and four subdimensions (anxiety symptoms, rumination, behavioral symptoms, and concern about personal impact), with each item rated on a five-point Likert scale (0 = not at all, 1 = some days, 2 = most days, 3 = nearly every day). Higher scores on the scale indicate higher levels of eco-anxiety.
Baseline and 15 days after completion of the education program
Perceived Vulnerability to Disease
Change in parents' perceived vulnerability to disease measured using the Perceived Vulnerability to Disease Scale. The scale consists of a total of 15 items and two subdimensions: Perceived Infectability (items 2, 5, 6, 8, 10, 12, and 14) and Germ Aversion (items 1, 3, 4, 7, 9, 11, 13, and 15). Items 3, 5, 11, 12, 13, and 14 are reverse-scored. The total score obtainable from the scale ranges from 7 to 105. The scale is structured as a seven-point Likert type, ranging from 1 (strongly disagree) to 7 (strongly agree), and higher scores indicate a higher perceived vulnerability to diseases.
Baseline and 15 days after completion of the education program
Study Arms (2)
Arm 1 (Experimental): Structured Education
EXPERIMENTALParticipants assigned to this arm will receive a structured, face-to-face education program delivered in a primary health care setting. The program consists of three weekly sessions, each lasting approximately 30-40 minutes. The education covers childhood vaccination, vaccine hesitancy, digital vaccine literacy, eco-anxiety, and perceived vulnerability to diseases.
Arm Type: Control Group (No Intervention)
NO INTERVENTIONParticipants assigned to this arm will receive routine services provided by the Family Health Center. No additional educational intervention will be administered during the study period.
Interventions
A structured education program consisting of three face-to-face sessions delivered once per week in a primary health care setting. Each session lasts approximately 30-40 minutes and focuses on childhood vaccination, vaccine hesitancy, digital vaccine literacy, eco-anxiety, and perceived vulnerability to diseases.
Eligibility Criteria
You may qualify if:
- Parents who have at least one child aged 0-2 years
- Attendance at the Van Tuşba Family Health Center
- Ability to read and write in Turkish
- Willingness to participate voluntarily in the study
- Provision of written informed consent
You may not qualify if:
- Individuals with a diagnosed psychiatric disorder
- Individuals with cognitive or sensory impairments that prevent effective communication
- Individuals who are unable to attend the education sessions
- Individuals who do not complete the baseline assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Van Yuzuncu Yil University
Van, Van, 65100, Turkey (Türkiye)
Related Publications (2)
Betsch C, Brewer NT, Brocard P, et al. Opportunities and challenges of Web 2.0 for vaccination decisions. Vaccine. 2018;36(25):3727-3733. doi:10.1016/j.vaccine.2018.02.025
RESULTWorld Health Organization. Ten threats to global health in 2019. World Health Organization; 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor / Dr.
Study Record Dates
First Submitted
January 25, 2026
First Posted
February 2, 2026
Study Start
January 20, 2026
Primary Completion
February 20, 2026
Study Completion
March 9, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical considerations and the absence of explicit consent for data sharing in the informed consent process. Data will be used only for the purposes of the present study and reported in aggregate form to ensure participant confidentiality.